18
Participants
Start Date
September 30, 2005
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
Seretide
Combination of inhaled corticosteroids (250 microgr) and inhaled long-acting beta2-agonists (25 microgr)
Placebo
Inhaled sugar powder in a placebo inhaler
Respiratory and Allergy Research Unit, Department of Respiratory Medicine, Bispebjerg Hospital, Copenhagen
Collaborators (1)
Imperial College London
OTHER
Anti Doping Danmark
OTHER
GlaxoSmithKline
INDUSTRY
The Research Foundation of Bispebjerg Hospital
UNKNOWN
Ragnhild Ibsens Legat For Medicinsk Forskning
OTHER
Bispebjerg Hospital
OTHER